Masculinizing chest wall gender-affirming surgery: Clinical outcomes of 73 subcutaneous mastectomies using the double-incision and semicircular incision techniques
Journal of Plastic, Reconstructive & Aesthetic Surgery · 2023-10 · 85 · 515-522
DOI: 10.1016/j.bjps.2023.02.020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Plastic, Reconstructive & Aesthetic Surgery, 2023-10. Verfasst von Doga Kuruoglu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Plastic Surgery, Department of Surgery, Mayo Clinic, Rochester, MN, USA. Hauptthemen laut MEDLINE: Thoracic Wall, Mastectomy, Subcutaneous, Gender-Affirming Surgery, Breast Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Masculinizing chest wall gender-affirming surgery is an important element in the treatment of gender dysphoria. In this study, we report an institutional series of subcutaneous mastectomies and aim to identify the risk factors for major complications and revision surgery. A retrospective review of consecutive patients who underwent primary masculinizing top surgery via subcutaneous mastectomy at our institution through July 2021 was performed. Demographics and clinical characteristics were recorded as well as major complications and revision surgeries. Time-to-event analyses were performed to assess predictors of major complications and revision surgery. Seventy-three consecutive patients (146 breasts) were included. The mean age and the mean body mass index were 25.2 ± 7 years and 27.6 ± 6.5 kg/m2, respectively. The mean follow-up time was 7.9 ± 7.5 months. None of the patients had a history of chest wall radiation or breast surgery. Double incision with free nipple grafting was the most common technique (n = 130, 89%), followed by periareolar semicircular incision (n = 16, 11%). The mean resection weight was 524.7 ± 377.7 g. Concomitant suction-assisted lipectomy was performed in 48 (32.9%) cases. The rate of major complications was 2.7%. Revision surgery was performed in 8 (5.4%) cases. Concomitant liposuction was significantly associated with a lower rate of revision surgery (p = 0.026). Masculinizing chest wall gender-affirming surgery is a safe procedure with a low rate of revision. Concomitant liposuction significantly reduced the need of revision surgery. Future studies utilizing patient-reported outcomes are still required to better assess the success of this procedure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Plastic Surgery, Department of Surgery, Mayo Clinic, Rochester, MN, USA.
- Department of Surgery, Mayo Clinic, Rochester, MN, USA.
- Mayo Clinic Alix School of Medicine, Mayo Clinic, Rochester, MN, USA.
- Division of Plastic Surgery, Department of Surgery, Mayo Clinic, Rochester, MN, USA. Electronic address: MartinezJorge.Jorys@mayo.edu.
Zitieren
APA
Kuruoglu, D., Alsayed, A. S., Melson, V. A., Figueroa, N. S., Fahradyan, V., & Martinez-Jorge, J. (2023). Masculinizing chest wall gender-affirming surgery: Clinical outcomes of 73 subcutaneous mastectomies using the double-incision and semicircular incision techniques. Journal of Plastic, Reconstructive & Aesthetic Surgery, 85, 515-522. https://doi.org/10.1016/j.bjps.2023.02.020
Vancouver
Kuruoglu D, Alsayed AS, Melson VA, Figueroa NS, Fahradyan V, Martinez-Jorge J. Masculinizing chest wall gender-affirming surgery: Clinical outcomes of 73 subcutaneous mastectomies using the double-incision and semicircular incision techniques. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2023;85:515-522. doi:10.1016/j.bjps.2023.02.020
BibTeX
@article{Kuruoglu2023,
author = {Kuruoglu, Doga and Alsayed, Ahmed S and Melson, Valerie A and Figueroa, Nicole Sanchez and Fahradyan, Vahe and Martinez-Jorge, Jorys},
title = {Masculinizing chest wall gender-affirming surgery: Clinical outcomes of 73 subcutaneous mastectomies using the double-incision and semicircular incision techniques},
journal = {Journal of Plastic, Reconstructive & Aesthetic Surgery},
year = {2023},
volume = {85},
pages = {515--522},
doi = {10.1016/j.bjps.2023.02.020}
}
EUVIMED